QR kȏd

Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis

Bacterial keratitis (BK) is a critical ocular infection that can lead to serious visual disability. Ciprofloxacin (CIP), moxifloxacin (MOX), and levofloxacin (LFX) have been accepted as monotherapies by the US Food and Drug Administration for BK treatment. CIP is available commercially at 0.3% <i>w<...

Cijeli opis

Spremljeno u:
Glavni autori: Ahmed Adel Ali Youssef, Chuntian Cai, Narendar Dudhipala, Soumyajit Majumdar
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2021-03-01
Serija:Pharmaceuticals
Teme:
bacterial keratitis
ciprofloxacin
nanoemulsion
stability
transcorneal permeability
surfactant
Online pristup:https://www.mdpi.com/1424-8247/14/3/210
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti